首页> Oncotarget> miRNA-based signatures in cerebrospinal fluid as potential diagnostic tools for early stage Parkinson's disease.

miRNA-based signatures in cerebrospinal fluid as potential diagnostic tools for early stage Parkinson's disease.

导出 OA

翻译打印收藏纠错

第一作者： Marcia Cristina T,Dos Santos

第一单位： Experimental Medicine and Diagnostics, Global Exploratory Development, UCB Biopharma SPRL, Braine-l'Alleud, Belgium.

作者： Marcia Cristina T,Dos Santos ^[1] ; Miguel Arturo,Barreto-Sanz ^[2] ; Bruna Renata S,Correia ^[3] ; Rosie,Bell ^[4] ; Catherine,Widnall ^[5] ; Luis Tosar,Perez ^[6] ; Caroline,Berteau ^[5] ; Claudia,Schulte ^[7] ; Dieter,Scheller ^[8] ; Daniela,Berg ^[9] ; Walter,Maetzler ^[9] ; Pedro A F,Galante ^[3] ; Andre,Nogueira da Costa ^[1]

作者单位： Experimental Medicine and Diagnostics, Global Exploratory Development, UCB Biopharma SPRL, Braine-l'Alleud, Belgium. ^[1] SimplicityBio SA, Monthey, Switzerland. ^[2] Hospital Sirio Libanes, São Paulo, Brazil. ^[3] Centre for Misfolding Diseases, University of Cambridge, Cambridge, UK. ^[4] Leeds Institute of Biomedical and Clinical Sciences, University of Leeds, Leeds, UK. ^[5] Bioanalytical Sciences, Non Clinical Development, UCB Biopharma SPRL, Belgium. ^[6] Hertie Institute for Clinical Brain Research, Department of Neurodegeneration, University of Tuebingen and German Center for Neurodegenerative Diseases, Tuebingen, Germany. ^[7] Consultancy Neuropharm, Neukirchener, Neuss, Germany. ^[8] Hertie Institute for Clinical Brain Research, Department of Neurodegeneration, University of Tuebingen and German Center for Neurodegenerative Diseases, Tuebingen, Germany.;Department of Neurology, Christian-Albrechts-University Kiel, Kiel, Germany. ^[9]

关键词 CSF early stage PD diagnosis exosomal miRNA machine learning

DOI 10.18632/oncotarget.24736

PMID 29707120

发布时间 2019-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交